Cargando…

Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial

BACKGROUND: Tofacitinib is an oral Janus kinase inhibitor. This open-label, long-term extension (LTE) study (NCT00658359) evaluated long-term tofacitinib treatment in stable kidney transplant recipients (n = 178) posttransplant. METHODS: Patients who completed 12 months of cyclosporine (CsA) or tofa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busque, Stephan, Vincenti, Flavio G., Tedesco Silva, Helio, O’Connell, Philip J., Yoshida, Atsushi, Friedewald, John J., Steinberg, Steven M., Budde, Klemens, Broeders, Emine N., Kim, Yon Su, Hahn, Carolyn M., Li, Huihua, Chan, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133407/ https://www.ncbi.nlm.nih.gov/pubmed/30234149 http://dx.doi.org/10.1097/TXD.0000000000000819

Ejemplares similares

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients
por: Looney, Cary M., et al.
Publicado: (2023)

Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen
por: Phirom, Supitchaya, et al.
Publicado: (2022)

Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
por: Osmanodja, Bilgin, et al.
Publicado: (2021)

Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial
por: Webber, Allison B., et al.
Publicado: (2018)

A Randomized Controlled Trial of a Mobile Medical App for Kidney Transplant Recipients: Effect on Use of Sun Protection
por: Robinson, June K., et al.
Publicado: (2015)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and Retransplantation
por: Balakrishnan, Suryanarayanan, et al.
Publicado: (2022)

Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018)

Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis
por: Wehmeier, Caroline, et al.
Publicado: (2017)

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10
por: Mayer, Katharina A., et al.
Publicado: (2022)

The Impact of Withdrawal of Maintenance Immunosuppression and Graft Nephrectomy on HLA Sensitization and Calculated Chance of Future Transplant
por: Nimmo, Ailish M. S. A., et al.
Publicado: (2018)

Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin
por: Kable, Kathy, et al.
Publicado: (2017)

Reliability and Validity of the Japanese Version of the Basel Assessment of Adherence to Immunosuppressive Medications Scale in Kidney Transplant Recipients
por: Kosoku, Akihiro, et al.
Publicado: (2023)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

The Association Between Kidney Donor Profile Index and 1-y Graft Function
por: Foresto, Renato Demarchi, et al.
Publicado: (2023)

Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study
por: Bottomley, Matthew J., et al.
Publicado: (2016)

Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis
por: Nazzal, Mustafa, et al.
Publicado: (2018)

Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
por: van Sandwijk, Marit S., et al.
Publicado: (2018)

One-Year Outcomes of a Cohort of Renal Transplant Patients Related to BMI in a Steroid-Sparing Regimen
por: Bellini, Maria Irene, et al.
Publicado: (2017)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center
por: Kurian, Sunil M., et al.
Publicado: (2021)

Patient and Clinician Perceptions of Informed Consent and Decision Making About Accepting KDPI > 85 Kidneys
por: Schantz, Karolina, et al.
Publicado: (2021)

The Role of Procurement Biopsies in Kidney Acceptance Decision Making and Kidney Discard: Perceptions of Physicians, Nurse Coordinators, and OPO Staff and Directors
por: Schantz, Karolina, et al.
Publicado: (2022)

Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial
por: Gwinner, Wilfried, et al.
Publicado: (2022)

Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study
por: Pernin, Vincent, et al.
Publicado: (2023)

Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review
por: Wilson, Gregory J., et al.
Publicado: (2022)

One-year Outcome of Everolimus With Standard-dose Tacrolimus Immunosuppression in De Novo ABO-incompatible Living Donor Kidney Transplantation: A Retrospective, Single-center, Propensity Score Matching Comparison With Mycophenolate in 42 Transplants
por: Noguchi, Hiroshi, et al.
Publicado: (2019)

Low-dose Rituximab and Thymoglobulin Induction With Steroid-free Maintenance Immunosuppression and Protocol Biopsies Improves Long-term Patient and Graft Survival After Kidney Transplantation: Survival and Safety Outcomes in More Than 1100 Patients From a Single Center
por: Pathak, Vivek, et al.
Publicado: (2019)

mTOR Inhibition by Everolimus Does Not Impair Closure of Punch Biopsy Wounds in Renal Transplant Patients
por: Dutt, Shelley B., et al.
Publicado: (2017)

Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation
por: Collins, Michael G., et al.
Publicado: (2022)

Randomized Trial of Machine Perfusion Versus Cold Storage in Recipients of Deceased Donor Kidney Transplants With High Incidence of Delayed Graft Function
por: Tedesco-Silva, Helio, et al.
Publicado: (2017)

The World's Youngest Cadaveric Kidney Transplant: Medical, Surgical and Ethical Issues
por: Daar, Abdallah S., et al.
Publicado: (2016)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy
por: Luttropp, Karin, et al.
Publicado: (2016)

Successful Kidney Transplantation After Stepwise Desensitization Using Rituximab and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible High Titer Patient
por: Inui, Masashi, et al.
Publicado: (2016)

Classification of Kidney Transplant Recipients Using a Combination of Estimated GFR and Albuminuria Reflects Risk
por: White, Christine A., et al.
Publicado: (2016)

Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients
por: Unagami, Kohei, et al.
Publicado: (2016)

Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study
por: Wali, Ravinder K., et al.
Publicado: (2016)

HLA Matching Trumps Donor Age: Donor-Recipient Pairing Characteristics That Impact Long-Term Success in Living Donor Kidney Transplantation in the Era of Paired Kidney Exchange
por: Milner, John, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u52levp6sfms07kqmgutlggf4a